The Global Growth of Cardiac Biomarkers Diagnostics: Innovations, Growth Drivers, and Opportunities (2024-2029)
Frost & Sullivan
MARCH 28, 2025
This article explores key trends, growth opportunities, and market drivers in the cardiac biomarkers diagnostics industry from 2024 to 2029. Elabscience Biotechnology, Inc., Technological innovations, including high-sensitivity cardiac troponin assays, are significantly improving early detection and patient outcomes.
52 
Let's personalize your content